Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of Human Immunodeficiency Virus
Clinical Infectious Diseases · 27.05.2026
DOI: 10.1093/cid/ciag322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 27.05.2026. Verfasst von Tzu-Hao Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Tenofovir-sparing antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) are increasingly used. However, these regimens may increase the risk of new hepatitis B virus (HBV) infection or reactivation due to lack of full activity against HBV. The magnitude and mechanism of risk can vary by baseline HBV serologic profile and need to be discussed with the patient before switching regimens. Importantly, these risks can be mitigated through HBV screening, vaccination, and post-switch monitoring. Here, we synthesize the evidence across different clinical scenarios and propose a practical workflow to reduce the potential but preventable risk during transitions to tenofovir-sparing regimens. Finally, we highlight knowledge gaps and outline future research priorities. The decision to switch to tenofovir-sparing ART or PrEP should not be made solely through the lens of HIV efficacy and convenience and must incorporate HBV prevention and reactivation risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
- Division of Abdominal Transplant, Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
- Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, CA, USA.
- Greater Los Angeles VA Healthcare System, Los Angeles, California, USA, CA, USA.
- Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
- Madison Clinic and Liver Clinic, Harborview Medical Center, Seattle, WA, USA.
ORCID-Profile: Tzu-Hao Lee, Debika Bhattacharya, H Nina Kim
Zitieren
APA
Lee, T. H., Bhattacharya, D., & Kim, H. N. (2026). Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of Human Immunodeficiency Virus. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag322
Vancouver
Lee TH, Bhattacharya D, Kim HN. Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of Human Immunodeficiency Virus. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag322
BibTeX
@article{Lee2026,
author = {Lee, Tzu-Hao and Bhattacharya, Debika and Kim, H Nina},
title = {Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of Human Immunodeficiency Virus},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag322}
}
EUVIMED